Literature DB >> 23609349

The brain in late-onset glycogenosis II: a structural and functional MRI study.

Barbara Borroni1, M S Cotelli, E Premi, S Gazzina, M Cosseddu, A Formenti, R Gasparotti, M Filosto, A Padovani.   

Abstract

BACKGROUND: Late-onset glycogenosis type II (GSD II) is a rare, multisystem disorder mainly affecting limb and respiratory muscles due to acid alpha glucosidase deficiency. Despite evidence at autopsy of glycogen accumulation in the brain, no study exploring brain functions is yet available.
OBJECTIVE: Our objective in this study was to assess brain changes in late-onset GSD II.
METHODS: Each patient underwent a standardized neuropsychological assessment, regional grey-matter (GM) atrophy, and resting-state functional magnetic resonance imaging (RS-fMRI). Functional connectivity maps of the salience (SN) and default-mode (DMN) networks were considered. A group of age- and gender-matched healthy controls was enrolled for MRI comparisons. P values family-wise error (FWE) cluster level corrected inferior to 0.05 were considered.
RESULTS: Nine GSD II patients (age 46.6 ± 8.0; 55% male) were recruited. No significant GM atrophy was found in patients compared with controls (n = 18; age 48.0 ± 9.8,;40% male). Functional connectivity within the SN was selectively reduced in patients, and cingulate gyrus and medial frontal cortex were mainly involved. Accordingly, patients had significant impairment of executive functions (as measured by Wisconsin Card Sorting test), whereas other cognitive domains were within mean normal ranges.
CONCLUSIONS: Our findings extend the clinical spectrum of GSD II by indicating that brain changes occur in this muscular disorder. Above all, these results should lead to better examinations of therapeutic approaches and perspectives for the affected patients. Further studies evaluating in depth these issues are warranted.

Entities:  

Mesh:

Year:  2013        PMID: 23609349     DOI: 10.1007/s10545-013-9601-7

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  39 in total

Review 1.  Imaging genomics.

Authors:  Paul M Thompson; Nicholas G Martin; Margaret J Wright
Journal:  Curr Opin Neurol       Date:  2010-08       Impact factor: 5.710

2.  A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease.

Authors:  Priya S Kishnani; Wuh-Liang Hwu; Hanna Mandel; Marc Nicolino; Florence Yong; Deyanira Corzo
Journal:  J Pediatr       Date:  2006-05       Impact factor: 4.406

3.  Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy.

Authors:  B J Ebbink; F K Aarsen; C M van Gelder; J M P van den Hout; N Weisglas-Kuperus; J Jaeken; M H Lequin; W F M Arts; A T van der Ploeg
Journal:  Neurology       Date:  2012-04-25       Impact factor: 9.910

Review 4.  Diagnosis of glycogenosis type II.

Authors:  B Bembi; E Cerini; C Danesino; M A Donati; S Gasperini; L Morandi; O Musumeci; G Parenti; S Ravaglia; F Seidita; A Toscano; A Vianello
Journal:  Neurology       Date:  2008-12-02       Impact factor: 9.910

5.  The pattern of involvement of adult-onset acid maltase deficiency at autopsy.

Authors:  J D van der Walt; M Swash; J Leake; E L Cox
Journal:  Muscle Nerve       Date:  1987 Mar-Apr       Impact factor: 3.217

Review 6.  The natural course of non-classic Pompe's disease; a review of 225 published cases.

Authors:  Léon P F Winkel; Marloes L C Hagemans; Pieter A van Doorn; M Christa B Loonen; Wim J C Hop; Arnold J J Reuser; Ans T van der Ploeg
Journal:  J Neurol       Date:  2005-08       Impact factor: 4.849

7.  Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy.

Authors:  Yin-Hsiu Chien; Ni-Chung Lee; Shinn-Forng Peng; Wuh-Liang Hwu
Journal:  Pediatr Res       Date:  2006-07-20       Impact factor: 3.756

8.  Cognitive and adaptive functioning of children with infantile Pompe disease treated with enzyme replacement therapy: long-term follow-up.

Authors:  Gail A Spiridigliozzi; James H Heller; Priya S Kishnani
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-01-17       Impact factor: 3.908

9.  Composite neuropsychological batteries and demographic correction: standardization based on equivalent scores, with a review of published data. The Italian Group for the Neuropsychological Study of Ageing.

Authors:  E Capitani; M Laiacona
Journal:  J Clin Exp Neuropsychol       Date:  1997-12       Impact factor: 2.475

Review 10.  From sensation to cognition.

Authors:  M M Mesulam
Journal:  Brain       Date:  1998-06       Impact factor: 13.501

View more
  5 in total

Review 1.  Multisystem late onset Pompe disease (LOPD): an update on clinical aspects.

Authors:  Antonio Toscano; Carmelo Rodolico; Olimpia Musumeci
Journal:  Ann Transl Med       Date:  2019-07

Review 2.  An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond.

Authors:  Aditi Korlimarla; Jeong-A Lim; Priya S Kishnani; Baodong Sun
Journal:  Ann Transl Med       Date:  2019-07

3.  Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment.

Authors:  Federica Montagnese; E Barca; O Musumeci; S Mondello; A Migliorato; A Ciranni; C Rodolico; P De Filippi; C Danesino; A Toscano
Journal:  J Neurol       Date:  2015-02-12       Impact factor: 4.849

Review 4.  Non-muscle involvement in late-onset glycogenosis II.

Authors:  Massimiliano Filosto; Alice Todeschini; Maria Sofia Cotelli; Valentina Vielmi; Fabrizio Rinaldi; Silvia Rota; Mauro Scarpelli; Alessandro Padovani
Journal:  Acta Myol       Date:  2013-10

5.  Behavioral, social and school functioning in children with Pompe disease.

Authors:  Aditi Korlimarla; Gail A Spiridigliozzi; Mihaela Stefanescu; Stephanie L Austin; Priya S Kishnani
Journal:  Mol Genet Metab Rep       Date:  2020-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.